Journal
INTERNATIONAL JOURNAL OF ONCOLOGY
Volume 40, Issue 4, Pages 1189-1195Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/ijo.2011.1298
Keywords
curcumin analogue; signal transducer and activator of transcription 3; breast cancer
Categories
Funding
- National Natural Science Foundation of China [30971131]
- Chongqing Science & Technology Commission (the Natural Science Foundation of Chongqing, CSTC) [2009BB5077]
- Foundation of National Key Discipline in Laboratory Medicine [2010104]
- Key Laboratory of Diagnostic Medicine Designated by the Ministry of Education, Chongqing Medical University
Ask authors/readers for more resources
Curcumin, the active component of turmeric, has been shown to protect against carcinogenesis and prevent tumor development in cancer. In our study, we tested the efficacy of a synthetic curcumin analogue, known as hydrazinocurcumin (HC), in breast cancer cells. The results demonstrated that compared to curcumin, HC was more effective in inhibiting STAT3 phosphorylation and downregulation of an array of STAT3 downstream targets which contributed to suppression of cell proliferation, loss of colony formation, depression of cell migration and invasion as well as induction of cell apoptosis. It was concluded that HC is a potent agent in the inhibition of STAT3 with more favorable pharmacological activity than curcumin, and HC may have translational potential as an effective cancer therapeutic or preventive agent for human breast carcinoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available